The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends Prevnar 20 as an option for your eligible adult patients.2
Patient profiles to help you determine which of your adult patients are eligible to receive Prevnar 20.
Prevnar 20 was built on the efficacy of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).1,3